Résumé
We describe a pipeline to test gene function in brain organoids derived from mouse embryonic stem cells genetically modified with CRISPR/Cas9-based tools. First, we detail methods to affect gene expression in embryonic stem cells by CRISPR activation, CRISPR inhibition, or CRISPR/Cas9 editing, which result in transactivation, repression, and the introduction of a premature termination codon in the gene of interest, respectively. Next, we provide a detailed protocol to differentiate these mutant mouse embryonic stem cells into brain organoids and perform their molecular characterization.